The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.
about
Current molecular imaging of spinal tumors in clinical practice.PET/CT in Oncology: Current Status and Perspectives.Comparison of standardized uptake values measured on F-NaF PET/CT scans using three different tube current intensitiesMolecular mechanisms of bone 18F-NaF deposition.Particle disease on fluoride-18 (NaF) PET/CT imaging.The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology.Bone scan or (18)f-fluorodeoxyglucose positron emission tomography/computed tomography; which modality better shows bone metastases of breast cancer?Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesionsReceiver operating characteristic (ROC) curve for classification of (18)F-NaF uptake on PET/CT.Choline metabolism in cancer: implications for diagnosis and therapy.Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: current practice.Bone positron emission tomography with or without CT is more accurate than bone scan for detection of bone metastasis.(11)C-Choline and FDG PET/CT Imaging of Primary Cholangiocarcinoma: A Comparative Analysis.RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study.Nuclear imaging of molecular processes in cancer.Imaging metastatic bone disease from carcinoma of the prostate18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their typeDiagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons.Detecting Tumor Metastases: The Road to Therapy Starts Here.A cell permeable peptide analog as a potential-specific PET imaging probe for prostate cancer detection.Complementary findings on 18F-FDG PET/CT and 18F-NaF PET/CT in a patient with Erdheim-Chester disease.18 F-Fluoride positron emission tomography/computed tomography for noninvasive in vivo quantification of pathophysiological bone metabolism in experimental murine arthritis.Role of (18)F-choline PET/CT in evaluation of patients with prostate carcinoma.The effects of muscle exercise and bed rest on [18F]methylcholine PET/CT.Synthetic approach for unsaturated precursors for parahydrogen induced polarization of choline and its analogs.Incidental diagnosis of a PSA-negative prostate cancer by 18FDG PET/CT in a patient with hypopharyngeal cancer.Is there still a role for SPECT–CT in oncology in the PET–CT era?
P2860
Q30476277-5E48A65C-156E-45FB-A8B2-4881BEF4F20BQ33665109-BA771C71-3482-4AF6-A6CF-F08C5588815EQ35195454-128DD90D-E1AE-4B5B-AFA5-7A5B9B3200A2Q35203602-07D6275D-91CC-4A86-87CD-E4EC605B94B5Q35829314-DF8A27E4-7611-44C0-9D9F-C77111675083Q36326885-445CE3F5-C253-4B63-BBF1-EF840A8112A6Q36457878-A01FEC41-CA20-4B85-A689-B316ACB3A015Q36627805-566FB676-4B1D-4BC3-A01A-45F04A1A8B41Q36628451-DB0A94F9-C651-4A74-8C58-F6DE8CBE3932Q36670926-4734631C-24B6-40D9-8B31-FC5AD9ECDE29Q36736397-30AD191D-1094-4E4D-ADC7-DA3D2BE7E0D6Q36847805-52E0D085-794C-4681-B446-8CF7067F2065Q37077299-EFCA8D0E-EAA9-4DF1-8FCF-E7047B2EF69CQ37357942-8851DF8E-ED52-4F94-BB38-B7F645E192F1Q37603124-76B933FD-CDC4-4AEB-8565-FD2BC3464EA8Q37605543-7CCE253F-6E8A-42D9-8200-3E4F14D19DCFQ38082417-F75EDC9C-D9B6-4A16-86D2-7E8F3520FC2CQ38766102-FDF0834A-C0AD-4180-8FB0-52F36607C377Q38950545-AB176FAC-7256-471C-9251-66E6AEF7710CQ39729101-02C97976-A6EF-4FBB-AF7C-3EBB4BBF2DD7Q41026235-69C6775A-DD51-40BC-B8BC-7B55198E49F3Q41811951-63B93332-1A8F-4375-9C57-D9E55B3F7D85Q41923981-86EBE554-474B-4B5D-81BA-2D8C1154832AQ42591261-BB2D8304-6A2D-4899-AC08-347A31E7FDEBQ42871596-3B333172-9246-49EE-A44E-DBA39E06979CQ53495411-8C7BD72E-64C0-408F-BB43-38247D59A604Q57758848-98C93410-DDFE-4528-9E30-1823C1AC94FC
P2860
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The role of fluorodeoxyglucose ...... phasis on prostate and breast.
@ast
The role of fluorodeoxyglucose ...... phasis on prostate and breast.
@en
type
label
The role of fluorodeoxyglucose ...... phasis on prostate and breast.
@ast
The role of fluorodeoxyglucose ...... phasis on prostate and breast.
@en
prefLabel
The role of fluorodeoxyglucose ...... phasis on prostate and breast.
@ast
The role of fluorodeoxyglucose ...... phasis on prostate and breast.
@en
P2093
P1476
The role of fluorodeoxyglucose ...... phasis on prostate and breast.
@en
P2093
Ignac Fogelman
Martin Heinisch
Werner Langsteger
P356
10.1053/J.SEMNUCLMED.2005.09.002
P577
2006-01-01T00:00:00Z